NEW YORK (GenomeWeb News) – Health Discovery Corporation has partnered with DCL Medical Laboratories to develop and commercialize DCL’s diagnostic tests for ovarian, cervical, and endometrial cancers.
Under the agreement, Savannah, Ga.-based HDC will own the developed intellectual property and DCL will have a sole-use license for applications and new mathematical tools that are developed over the course of the collaboration.
DCL’s support vector machine-based molecular diagnostic tests will be performed on digital images to help doctors provide more accurate diagnoses on biopsy and surgical specimens.
HDC is focused on SVM-based molecular diagnostic tests in genomics, proteomics, digital image analysis, and radiology.
Financial terms of the agreement were not released.